Ikarian Capital, LLC Clene Inc. Put Options Transaction History
Ikarian Capital, LLC
- $714 Million
- Q1 2025
Put Options
1 transactions
Others Institutions Holding CLNN
# of Institutions
6Shares Held
230KCall Options Held
0Put Options Held
25K-
Morgan Jess S & CO Inc112KShares$291,2000.27% of portfolio
-
Black Rock Inc. New York, NY83.5KShares$216,9720.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ25.2KShares$65,5980.0% of portfolio
-
Jefferies Group LLC New York, NY4.96KShares$12,8850.0% of portfolio
-
Cutler Group LP3.9KShares$10,1400.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $165M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...